The FDA has removed the Risk Evaluation and Mitigation Strategies program for vandetanib.Vandetanib (Caprelsa, Sanofi), a ...
A research project using artificial intelligence (AI) to improve natural disaster risk assessment is nearing successful completion, the Eratosthenes Centre of Excellence announced on Monday.The ...
On August 27, 2025, the U.S. Court of Appeals for the Second Circuit issued an opinion highlighting that, when public companies disclose risks using hypothetical language, those disclosures may be ...